ROBO1 CAR-T CELL THERAPY FOR TREATMENT REFRACTORY BRAIN CANCER

BTFC travel award recipient Glioblastoma (GBM) is the most common malignant adult brain tumor, with a dismal prognosis. Despite the multimodal treatment regimen, tumor recurrence is inevitable, and no standardized treatment exists for recurrent glioblastoma (rGBM). Neurodevelopment signaling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaikh, Muhammad Vaseem, Chokshi, Chirayu R, Brakel, Benjamin, Anand, Alisha, Maich, William Thomas, Suk, Yujin, Kieliszek, Agata, Subapanditha, Minomi, Alizada, Zahra, Venugopal, Chitra, Rossotti, Martin A, Moffat, Jason, Henry, Kevin A, Kislinger, Thomas, Singh, Sheila K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337552/
http://dx.doi.org/10.1093/noajnl/vdad071.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337552/
http://dx.doi.org/10.1093/noajnl/vdad071.009

Ejemplares similares